Table 3 Outcomes of critically ill patients in the 4 groups.

From: Comparison of mortality and outcomes of four respiratory viruses in the intensive care unit: a multicenter retrospective study

 

Total n = 807

RSV n = 151

COVID-19 n = 332

Seasonal influenza n = 258

H1N1 influenza n = 66

P

Length of stay in ICU (days)

8 [4; 20]

7 [4; 15]

11 [4; 25]

6 [3; 13]

11 [6; 24]

 < 0.001

Mortality in ICU

229 (28%)

44 (29%)

92 (28%)

64 (25%)

29 (44%)

0.022

SOFA at Day 1

6 [3; 10]

8 [4; 11]

4 [2; 8]

8 [5; 11]

9 [5; 12]

 < 0.001

SOFA at Day 7

7 [4; 11]

7 [3; 9]

9 [5; 11]

5 [3; 8]

8 [4; 12]

 < 0.001

SOFA at Day 14

7 [4; 11]

5 [2; 10]

8 [4; 11]

4 [3; 8]

9 [4; 13]

 < 0.001

SOFARANK from day 1 to 14

 

− 39 [− 81; 5]

0 [-12; 70]

− 15 [− 58; 19]

10 [− 32; 92]

 < 0.001

  1. Data are presented as median [IQR] or n (%). SOFA, sepsis-related organ failure assessment. P value are estimated for the heterogeneity among the four groups.
  2. Significant values are in bold.
Back to article page